A transgenic animal is one whose genome has been deliberately altered to carry genetic material from another species or to have its own genes edited for specific traits.1PubMed Central. A review of transgenic animal techniques and their applications They are created for a wide range of purposes: to study how diseases work, to produce human medicines in animal milk, to grow organs suitable for human transplantation, to make livestock resistant to devastating infections, and even to suppress mosquito populations that spread dengue and malaria. What started in the early 1980s with mice has expanded into pigs, goats, fish, and insects, and the reasons for making these animals have grown just as varied.
How Transgenic Animals Are Made
The oldest and still most common technique is pronuclear microinjection, where a tiny needle delivers foreign DNA directly into a fertilized egg. In rodents, this works reasonably well and has been the workhorse of mouse genetics for decades.2PubMed Central. Lentiviral Mediated Production of Transgenic Mice: A Simple and Highly Efficient Method for Direct Study of Founders The injected egg is then implanted into a surrogate mother, and some fraction of the offspring will carry the new gene integrated into their chromosomes. It sounds straightforward, and conceptually it is, but the process is inefficient in larger animals like pigs and cattle. Success rates with microinjection in farm animals are extremely low compared to mice.3PubMed Central. Efficient transgenesis in farm animals by lentiviral vectors
To get around this bottleneck, researchers developed lentiviral vector methods. These use modified viruses to shuttle genes into fertilized eggs, and they can produce transgenic founders at rates above 70% in mice, far higher than conventional injection.2PubMed Central. Lentiviral Mediated Production of Transgenic Mice: A Simple and Highly Efficient Method for Direct Study of Founders More recently, CRISPR-based gene editing has entered the picture, allowing researchers to make precise changes to existing genes rather than just adding new ones. This distinction matters: classical transgenesis inserts foreign DNA somewhat randomly, while CRISPR can target a specific spot in the genome with high accuracy. Both approaches fall under the broad umbrella of genetically modified animals, but they give researchers very different levels of control over what changes and where.
Modeling Human Disease
One of the most influential uses of transgenic animals has been building models of human diseases that are otherwise impossible to study in a lab. Alzheimer’s disease is a good example. Researchers discovered that certain inherited mutations in genes for amyloid precursor protein and presenilin proteins cause familial forms of Alzheimer’s. By inserting those same mutations into mice, they created animals that develop amyloid plaques and other hallmarks of the disease.4PubMed Central. Transgenic mouse models of Alzheimer’s disease
No mouse model perfectly replicates the full scope of human Alzheimer’s, which involves not just plaques but also tangled proteins, neuron death, inflammation, and progressive dementia. But these models have provided real insights into how different forms of the amyloid protein damage the brain, and they have been essential testing grounds for potential treatments. The immunotherapy approaches for Alzheimer’s that reached clinical trials in humans were developed and tested in transgenic mice first.4PubMed Central. Transgenic mouse models of Alzheimer’s disease Other transgenic models exist for cancer, diabetes, cardiovascular disease, and a long list of neurological conditions. In each case, the logic is the same: give an animal a version of the disease so you can study it up close and test interventions before trying anything in people.
Producing Pharmaceuticals in Animal Milk
Some human proteins needed as medicines are difficult and expensive to manufacture in traditional cell-culture systems. Transgenic animals offer an alternative: engineer a goat, sheep, or rabbit so that a human protein gene is linked to a milk-production signal, and the animal will secrete the protein in its milk. You then purify the drug from the milk.
The most prominent success story is human antithrombin, a protein that prevents dangerous blood clotting. Transgenic goats were engineered to produce it, and the resulting drug, marketed as ATryn, became the first recombinant protein from a transgenic animal approved for clinical use, first in Europe in 2006 and then in the United States in 2009.5Brazilian Archives of Biology and Technology. Production of recombinant proteins in milk of transgenic and non-transgenic goats – Section: Antithrombin III Testing showed that the goat-produced antithrombin had the same biological activity as the version purified from human blood plasma, but actually bound heparin (a partner molecule) about four times more strongly. The appeal is partly economic: a small herd of transgenic goats can produce quantities of a protein that would require enormous and costly cell-culture bioreactors to match.
Growing Organs for Human Transplant
Thousands of people die every year waiting for organ transplants. Pig organs are roughly the right size for humans, which has made pig-to-human transplantation, called xenotransplantation, a long-held goal. The central problem is immunological: the human immune system attacks pig tissue almost immediately. Much of this rejection traces to sugar molecules on the surface of pig cells, particularly one called alpha-1,3-galactose, which human antibodies recognize as foreign and destroy on contact.6PubMed. Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies
The solution has been to genetically modify pigs, step by step, to make their organs more compatible. Researchers knocked out the genes for the three known sugar molecules that trigger human antibody attacks, then added human genes for proteins that regulate complement (part of the immune cascade), control blood clotting, and reduce inflammation.7PubMed Central. The Evolution of Immunosuppressive Therapy in Pig-to-Nonhuman Primate Organ Transplantation The most advanced pigs now carry ten genetic modifications: four pig genes knocked out and six human genes inserted. Hearts and kidneys from these pigs have been tested in preclinical models, and two clinical cases of pig-to-human heart transplantation were performed at the University of Maryland using hearts from this same line of pigs.8PubMed Central. Physiological basis for xenotransplantation from genetically modified pigs to humans The field is still early and still working through rejection issues, but transgenic pigs represent the most concrete hope for addressing the organ shortage.
Agricultural Applications
In agriculture, the goal is usually to make animals grow faster, resist disease, or produce better food. Growth hormone transgenic salmon are a well-studied example. Coho salmon engineered to overexpress growth hormone can reach body sizes more than seven times that of their unmodified counterparts when competing for food under certain conditions.9PubMed Central. Population effects of growth hormone transgenic coho salmon depend on food availability and genotype by environment interactions Interestingly, these transgenic fish also show some unexpected traits. Their inner ear stones, called otoliths, had a lower rate of a mineral defect called vaterite deposition compared to non-transgenic fish of matching size, suggesting that the growth hormone itself may play a protective role independent of growth speed.10PubMed Central. Fast-growing growth hormone transgenic coho salmon (Oncorhynchus kisutch) show a lower incidence of vaterite deposition and malformations in sagittal otoliths
Disease resistance in livestock may be an even bigger prize. Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most economically devastating pig diseases worldwide. The virus enters pig cells through a surface receptor called CD163. Using CRISPR, researchers modified the CD163 gene in pigs so that it no longer serves as a gateway for the virus while still performing its normal biological function of clearing certain waste molecules from the blood. When these edited pigs were exposed to a highly pathogenic strain of the virus, three of four survived and recovered, while all unmodified pigs died.11PubMed Central. Generation of Pigs Resistant to Highly Pathogenic-Porcine Reproductive and Respiratory Syndrome Virus through Gene Editing of CD163 Separate work showed that immune cells from pigs with a related CD163 edit were completely resistant to both major genotypes of the virus.12PLoS Pathogens. Precision engineering for PRRSV resistance in pigs: Macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function
Controlling Disease-Carrying Insects
Transgenic technology is not limited to vertebrates. One of its most striking field applications has been in mosquito control. Aedes aegypti mosquitoes transmit dengue, Zika, chikungunya, and yellow fever. Researchers developed a transgenic strain of male Aedes aegypti carrying a gene that causes offspring to die before reaching adulthood. Because these males mate with wild females but produce no viable young, sustained releases of transgenic males can crash the local mosquito population. In a field trial in Brazil, this approach reduced the estimated adult Aedes aegypti population by about 95% in the treated area.13PLoS Neglected Tropical Diseases. Suppression of a Field Population of Aedes aegypti in Brazil by Sustained Release of Transgenic Male Mosquitoes
Beyond sterile-male releases, researchers are also exploring gene drives, which use CRISPR-based systems to force a genetic modification to spread through a wild population faster than normal inheritance would allow. In mosquitoes, the idea is to either suppress populations by impairing female fertility or make mosquitoes unable to harbor the malaria parasite.14Highlights in Science, Engineering and Technology. Gene Drive System Based on CRISPR/Cas9 in Mosquito Control for Preventing Malaria Gene drives are also being considered for controlling invasive vertebrates like rats and mice on islands, though the design challenges are substantial and the ecological stakes are high.15PubMed Central. Dodging silver bullets: good CRISPR gene-drive design is critical for eradicating exotic vertebrates The broader concept, called genetic biocontrol, covers approaches ranging from simple sterile releases to these more aggressive self-propagating gene drives.16PubMed Central. Genetic Biocontrol for Invasive Species
Neuroscience and Basic Research Tools
Many transgenic animals are never intended for agriculture, medicine production, or any applied purpose. They exist as research tools. In neuroscience, transgenic mice have become indispensable for a technique called optogenetics, where specific neurons are engineered to respond to light. Mice are bred with genes for light-sensitive proteins, such as channelrhodopsins (which activate neurons) or halorhodopsins (which silence them), linked to promoters that restrict expression to certain types of brain cells. Shining light through a tiny fiber optic cable then lets researchers turn individual circuits on or off in a living, behaving animal. This approach has reshaped our understanding of how brain circuits control movement, motivation, fear, and reward.
The same principle of tissue-specific gene expression underpins a vast range of transgenic mouse tools. A system called Cre-loxP lets researchers activate or delete a gene only in a chosen cell type or at a chosen time.17PubMed Central. Mouse Cre-LoxP system: general principles to determine tissue-specific roles of target genes You can, for instance, knock out a gene only in liver cells and see what happens, while the rest of the animal’s body is unaffected. Researchers achieve this specificity by using promoter sequences, the stretches of DNA that tell cells when and where to turn on a gene. Some promoters are active only in one tissue: early work showed that a collagen gene promoter drove expression in connective tissues but not elsewhere, and a uroplakin promoter worked only in the bladder lining.18Journal of Biological Chemistry. Tissue-specific expression of the mouse alpha 2(I) collagen promoter. Studies in transgenic mice and in tissue culture cells19PubMed. A tissue-specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice These precision tools make modern biomedical research possible in ways that were unthinkable before transgenesis.
Why the Science Is Harder Than It Sounds
Even when a transgene is successfully inserted and the animal is born healthy, getting the gene to behave as expected is not guaranteed. A major headache is something called position effect: where in the genome the transgene happens to land can dramatically affect whether it works at all. Transgenes that integrate near the ends of chromosomes, called telomeres, are expressed at very low levels compared to the same transgenes at other locations. Over time, these telomeric transgenes can become completely silenced through a process involving DNA methylation, a chemical modification that shuts genes down.20PubMed Central. Telomere position effect and silencing of transgenes near telomeres in the mouse
It gets even more surprising. The orientation of the transgene within its landing spot matters too. At some integration sites, the same gene cassette will be actively expressed when pointing one direction along the chromosome but silenced when pointing the other way.21PubMed. Position effects are influenced by the orientation of a transgene with respect to flanking chromatin This means that two animals carrying the exact same transgene can show completely different levels of expression depending on where and how the DNA landed. Researchers have to screen multiple founder animals and select those with good expression, which adds time and cost. Newer targeted-integration methods, including those using CRISPR to insert genes at predetermined “safe harbor” sites, are reducing but not eliminating this unpredictability.
Environmental and Ecological Risks
When transgenic animals are engineered for agricultural or environmental applications, a persistent worry is what happens if they escape into the wild. The concern is especially acute for fish, which are hard to physically contain and can interbreed with wild relatives. Growth hormone transgenic salmon that dramatically outgrow wild fish could, in theory, outcompete wild populations for food and mates, potentially disrupting ecosystems.
The reality is more complicated than a simple “super-fish takes over” narrative. Research has shown that how a transgenic animal performs relative to its wild counterpart depends heavily on the environment. A transgenic fish that dominates in a food-rich lab tank may fare very differently in a stream where food is scarce. These genotype-by-environment interactions mean that lab-based risk assessments can overestimate or underestimate the actual ecological threat.22PubMed Central. Gene-environment interactions influence ecological consequences of transgenic animals The genetic background of wild populations also matters: a transgene may have different phenotypic effects when mixed into different wild gene pools, making risk a moving target.23Trends in Biotechnology. What Are Transgenic Animals and Why Are They Created? This uncertainty is a big part of why genetically engineered fish with enhanced growth have been slow to reach commercial markets despite being technically feasible for years. Physical and biological containment strategies, such as making transgenic fish sterile, remain critical backstops.
Animal Welfare Concerns
Creating transgenic animals raises real welfare questions that go beyond the general ethics of animal research. The process itself is not biologically neutral. Generating transgenic farm animals involves in vitro reproductive technologies that can lead to difficult births, fetal and neonatal deaths, and unusually large or abnormal offspring, a phenomenon called large offspring syndrome.24Journal of Animal Science. Transgenesis may affect farm animal welfare: a case for systematic risk assessment Beyond the reproductive process, the transgene itself can cause problems. If the foreign DNA inserts into the middle of an important host gene, it can disrupt that gene’s function, an unpredictable event called an insertional mutation. And if the transgene produces a biologically active protein at the wrong level or in the wrong tissue, it can have unanticipated health consequences for the animal.
Because the effects of a new transgene are not always obvious, researchers are expected to carefully assess each new line by comparing the modified animals to unmodified counterparts, monitoring for illness or unexpected death, and performing thorough postmortem examinations when problems arise.25ILAR Journal. Welfare Issues of Genetically Modified Animals – Section: Identification of Welfare Concerns This kind of systematic phenotyping is considered part of responsible practice, but it does not eliminate the fact that some animals will suffer unanticipated harm. The welfare cost is one of the reasons regulatory bodies and ethics committees scrutinize transgenic animal proposals more closely than standard animal experiments.
How Transgenic Animals Are Regulated
In the United States, the Food and Drug Administration treats the intentional genomic alteration in an animal as a new animal drug, regardless of whether the animal is destined for a lab, a farm, or a pharmacy shelf. The evaluation is risk-based and involves four criteria: the modification must be safe for the animal, safe for human consumption if the product enters the food supply, effective at doing what the sponsor claims, and acceptable in terms of environmental impact under the National Environmental Policy Act.26PubMed Central. Genetically Modified Animal-Derived Products: From Regulations to Applications – Section: 2.3. FDA Criteria of Evaluation Each case is assessed individually, so there is no blanket approval or blanket ban.
The regulatory framework has drawn criticism for being slow and potentially out of step with the technology. Some scientists argue there is an urgent need for reform, particularly for genome-edited food animals that carry small, precise changes rather than large foreign gene insertions. The concern is that applying the same lengthy regulatory pathway to both a pig with a single base-pair edit and a goat secreting a human protein in its milk may be disproportionate, and that regulatory delays could prevent useful animals from reaching the market in time to address food security challenges in coming decades.27PubMed. Safety evaluation of transgenic and genome-edited food animals Other countries are developing their own frameworks, and the global regulatory landscape remains patchy.
Public Attitudes and Why They Are Complicated
Public opinion about transgenic animals does not reduce neatly to “for” or “against.” Research on attitudes toward genetically modified salmon found that people weigh multiple factors at once: perceived risks and benefits, familiarity with the technology, religious and ethical beliefs, trust in regulatory institutions, and broader feelings about whether modern biotechnology is a promise or a threat.28PubMed Central. Determinants of public attitudes to genetically modified salmon Religious acceptability turned out to be one of the strongest direct predictors of willingness to encourage GM salmon. People also cared about whether the product would be labeled and whether it would be patented, both of which tap into concerns about transparency and corporate control rather than safety per se.
This complexity means that public acceptance is not simply a knowledge problem solvable by explaining the science better. People may fully understand what a transgenic salmon is and still object to it on grounds that feel entirely legitimate to them, whether those grounds are about environmental risk, the ethics of altering animals, or discomfort with the commercial structures surrounding the technology. The practical implication for researchers and regulators is that public engagement has to address values and governance, not just safety data, if transgenic animal products are ever to gain broad social license.